MMP3, matrix metallopeptidase 3, 4314

N. diseases: 473; N. variants: 24
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.300 Biomarker group BEFREE With immunoblotting, qRT-PCR, and/or a fluorescence resonance energy transfer (FRET)-based activity assay, we next measured MMP-3/-9 since they are key effectors of BBB breakdown in stroke. 29527151 2018
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.300 AlteredExpression group BEFREE Accordingly, this study tested the hypothesis that tPA and HG increases MMP3 activity in the brain after stroke through peroxynitrite induced tyrosine nitration. 28975464 2018
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.300 Biomarker group BEFREE Male SHRSP, SHRSR, two reciprocal SHRSR/SHRSP-STR1/QTL stroke congenic lines received JD for 4 weeks to detect brain UCP2 gene/protein modulation as compared with regular diet (RD). 28640254 2017
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.300 Therapeutic group RGD Candesartan reduces the hemorrhage associated with delayed tissue plasminogen activator treatment in rat embolic stroke. 24194350 2013
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.300 GeneticVariation group BEFREE We investigated the association of single nucleotide polymorphisms (SNPs) of the MMP3 gene with stroke in the Korean population. 22175304 2012
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.300 GeneticVariation group BEFREE MMP-1 (-1607 G in/del), MMP-3 (-1171 A in/del), and MMP-9 microsatellite ((13-26) CA repeats around -90) PMs have been determined (i) in 204 patients with cerebrovascular disease to assess the association with features of vulnerability in carotid plaques and prevalence of stroke, (ii) in 208 patients with UA/NSTEMI to assess the association with in-hospital clinical outcome. 21232745 2011
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.300 Biomarker group BEFREE The aim of this study was to evaluate the association of genetic variants within the genes encoding tumor necrosis factor-α (TNF-α) and matrix metalloproteinase-3 (MMP-3), with stroke. 21219546 2011
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.300 GeneticVariation group BEFREE The MMP3 6A/6A genotype is associated with an increased risk of stroke in hypertensive subjects taking lisinopril compared with patients treated with chlorthalidone, whereas a protective effect was found for 5A/5A individuals treated with lisinopril. 21183746 2011
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.300 Biomarker group BEFREE Furthermore, inhibition of LRP suppressed both MMP-3 induction in endothelial cells and the increase in ICB by t-PA treatment after stroke. 19608750 2009
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.300 GeneticVariation group BEFREE No individual SNP identified MMP3 haplotype 2, and none of the individual MMP3 SNPs were associated with myocardial infarction or stroke. 18342317 2008
CUI: C0038454
Disease: Cerebrovascular accident
Cerebrovascular accident
0.300 Biomarker group BEFREE The likely candidate genes associated with stroke are those that are associated with matrix deposition (stromelysin-1, MMP3), inflammation (IL-6), and lipid metabolism (hepatic lipase, APOE, PON1) and clotting (factor V Leiden, fibrinogen). 15767859 2005